Healthcare Realty Trust Inc (HR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 500M 1B 1.5B Q3 '15: 396.8M Q4 '15: 403.8M Q1 '16: 412.6M Q2 '16: 426.5M Q3 '16: 440.9M Q4 '16: 460.9M Q1 '17: 478M Q2 '17: 504.6M Q3 '17: 562.3M Q4 '17: 614M Q1 '18: 665.3M Q2 '18: 698.8M Q3 '18: 697.9M Q4 '18: 696.4M Q1 '19: 689.7M Q2 '19: 688.2M Q3 '19: 688M Q4 '19: 692M Q1 '20: 708.9M Q2 '20: 715.9M Q3 '20: 728.3M Q4 '21: 596M Q1 '22: 547.4M Q2 '22: 561.3M Q3 '22: 731M Q4 '22: 932.6M Q1 '23: 1.1B Q2 '23: 1.3B Q3 '23: 1.4B Q4 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.3B Q4 '24: 1.3B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.2B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.1B Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

0 60M 120M 180M Q4 '10: 21.5M Q1 '11: 26.1M Q2 '11: 32M Q3 '11: 34.5M Q4 '11: 47.3M Q1 '12: 45.8M Q2 '12: 31.5M Q3 '12: 31.3M Q4 '12: 29.6M Q1 '13: 31.6M Q2 '13: 52M Q3 '13: 61.2M Q4 '13: 66.3M Q1 '14: 73.3M Q2 '14: 73M Q3 '14: 75.3M Q4 '14: 83.1M Q1 '15: 86.9M Q2 '15: 91.7M Q3 '15: 92.4M Q4 '15: 93.6M Q1 '16: 97.8M Q2 '16: 99.4M Q3 '16: 101.4M Q4 '16: 101.9M Q1 '17: 103.9M Q2 '17: 101.7M Q3 '17: 117.2M Q4 '17: 123.6M Q1 '18: 129.7M Q2 '18: 148.9M Q3 '18: 143.7M Q3 '11 Q3 '12 Q3 '13 Q3 '14 Q3 '15 Q3 '16 Q3 '17 Q3 '18

Net Income TTM

-750M -500M -250M 0 250M 500M 750M Q3 '15: 43.8M Q4 '15: 32.9M Q1 '16: 36M Q2 '16: 39.8M Q3 '16: 39.7M Q4 '16: 45.9M Q1 '17: 49.6M Q2 '17: 30.6M Q3 '17: 37.9M Q4 '17: 63.9M Q1 '18: 60.2M Q2 '18: 81.4M Q3 '18: 240.7M Q4 '18: 213.5M Q1 '19: 217.1M Q2 '19: 218M Q3 '19: 36.6M Q4 '19: 30.2M Q1 '20: 34.6M Q2 '20: 31.8M Q3 '20: 33.5M Q4 '20: 72.2M Q1 '21: 76.3M Q2 '21: 85.9M Q3 '21: 90.7M Q4 '21: 64.7M Q1 '22: 84.9M Q2 '22: 67.9M Q3 '22: 98.3M Q4 '23: -278.3M Q1 '24: -502M Q2 '24: -563M Q3 '24: -588.2M Q4 '24: -654.5M Q1 '25: -388.5M Q2 '25: -402.6M Q3 '25: -367.3M Q4 '25: -246.1M Q1 '26: -201.3M Q2 '26: -86.9M Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 200M 400M 600M Q3 '16: 200.7M Q4 '16: 203.7M Q1 '17: 210.3M Q2 '17: 247.8M Q3 '17: 284M Q4 '17: 307.5M Q1 '18: 321.4M Q2 '18: 323.1M Q3 '18: 319.8M Q4 '18: 337.4M Q1 '19: 325.1M Q2 '19: 330M Q3 '19: 335M Q4 '19: 340.4M Q1 '20: 367.3M Q2 '20: 373.8M Q3 '20: 371.7M Q4 '20: 470.1M Q1 '21: 460M Q2 '21: 393.5M Q3 '21: 370.7M Q4 '21: 232.6M Q1 '22: 211M Q2 '22: 241.1M Q3 '22: 189M Q4 '22: 272.7M Q1 '23: 298.2M Q2 '23: 412.9M Q3 '23: 518.6M Q4 '23: 499.8M Q1 '24: 506.8M Q2 '24: 489.8M Q3 '24: 490.9M Q4 '24: 501.6M Q1 '25: 473.3M Q2 '25: 468.3M Q3 '25: 462.8M Q4 '25: 457.1M Q1 '26: 462.2M Q2 '26: 441.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

0 150M 300M 450M Q3 '16: 154.7M Q4 '16: 160.7M Q1 '17: 163.2M Q2 '17: 200.6M Q3 '17: 232.1M Q4 '17: 242.7M Q1 '18: 252.1M Q2 '18: 250.2M Q3 '18: 236.8M Q4 '18: 259.5M Q1 '19: 247.8M Q2 '19: 248.5M Q3 '19: 258.8M Q4 '19: 248.8M Q1 '20: 268.7M Q2 '20: 276.1M Q3 '20: 280.7M Q4 '20: 376.1M Q1 '21: 360.9M Q2 '21: 301.6M Q3 '21: 266.1M Q4 '21: 131.9M Q1 '22: 116M Q2 '22: 136.6M Q3 '22: 60.2M Q4 '22: 109.2M Q1 '23: 97.8M Q2 '23: 201M Q3 '23: 358.2M Q4 '23: 331.1M Q1 '24: 347.8M Q2 '24: 297.3M Q3 '24: 230M Q4 '24: 252.6M Q1 '25: 205.5M Q2 '25: 182.3M Q3 '25: 156.9M Q4 '25: 126.9M Q1 '26: 140M Q2 '26: 134.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '13: 227.8M Q3 '13: 235M Q1 '14: 119.9M Q2 '14: 120.3M Q3 '14: 120.7M Q1 '15: 127.1M Q2 '15: 127.1M Q3 '15: 128.8M Q1 '16: 131.2M Q2 '16: 140.5M Q3 '16: 143.1M Q1 '17: 146.1M Q2 '17: 176.5M Q3 '17: 204.8M Q1 '18: 209.2M Q2 '18: 209.3M Q3 '18: 211.4M Q1 '19: 209M Q2 '19: 209M Q3 '19: 205.3M Q1 '20: 220.6M Q2 '20: 222.1M Q3 '20: 218.5M Q1 '21: 222.3M Q2 '21: 142M Q3 '21: 143.8M Q1 '22: 149.1M Q2 '22: 149.7M Q3 '22: 332M Q1 '23: 378.8M Q2 '23: 378.9M Q3 '23: 378.9M Q1 '24: 379.5M Q2 '24: 372.5M Q3 '24: 359M Q1 '25: 349.5M Q2 '25: 349.6M Q3 '25: 350M Q1 '26: 347.4M Q2 '26: 342.3M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q3 '15: 0.34 Q4 '15: 0.25 Q1 '16: 0.28 Q2 '16: 0.30 Q3 '16: 0.29 Q4 '16: 0.33 Q1 '17: 0.34 Q2 '17: 0.22 Q3 '17: 0.25 Q4 '17: 0.35 Q1 '18: 0.31 Q2 '18: 0.41 Q3 '18: 1.16 Q4 '18: 1.02 Q1 '19: 1.03 Q2 '19: 1.04 Q3 '19: 0.18 Q4 '19: 0.14 Q1 '20: 0.16 Q2 '20: 0.14 Q3 '20: 0.15 Q4 '20: 0.52 Q1 '21: 0.54 Q2 '21: 0.64 Q3 '21: 0.65 Q4 '21: 0.38 Q1 '22: 0.56 Q2 '22: 0.44 Q3 '22: 0.54 Q4 '23: -0.74 Q1 '24: -1.33 Q2 '24: -1.50 Q3 '24: -1.58 Q4 '24: -1.79 Q1 '25: -1.10 Q2 '25: -1.16 Q3 '25: -1.07 Q4 '25: -0.71 Q1 '26: -0.58 Q2 '26: -0.26 Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.